Lokale Radiofrequenzablation von Leberherden - Möglichkeiten und Grenzen

Zusammenfassung

Die Radiofrequenzablation stellt die verbreitetste Methode der lokalen Thermotherapie der Leber dar. Sie ist relativ einfach in der Anwendung, beliebig wiederholbar und verbindet eine hohe Effektivität in der lokalen Zelldestruktion mit einer relativ geringen Komplikationsrate. In dieser Übersichtsarbeit werden das Prinzip der RF-Ablation (RFA) und die zur Verfügung stehenden Systeme beschrieben. Danach wird ein Überblick über die Rationale hinter der RFA von Leberherden, klinische Indikationen, Ergebnisse sowie zu erwartende Komplikationen gegeben. Die Hauptproblematik der Beurteilung des onkologischen Erfolges der RFA besteht in der immer breiteren Anwendung bei vielen Tumorentitäten, ohne dass große kontrollierte und randomisierte Studien zur Wirksamkeit vorliegen. Aus technischer Sicht ist die Hauptlimitation der RFA bei allem Fortschritt der Technik die immer noch limitierte Größe der Koagulationsnekrose. Die Indikation zur RFA muss interdisziplinär gestellt werden. Prinzipiell sollte außer bei symptomatischen neuroendokrinen Metastasen eine komplette Tumorablation (ggf. in mehreren Sitzungen) angestrebt werden. Die Rolle einer additiven Chemotherapie in Kombination mit der RFA insbesondere bei der Behandlung von Lebermetastasen ist derzeit unklar.

Abstract

Radiofrequency ablation (RFA) is currently the most established technique for the local destruction of tumors within the liver. It is technically straightforward, can be repeated and combines a high efficiency in tissue destruction with a low to moderate incidence of complications. This review explains the principle of RFA and lists currently available systems. In addition, the rationale behind RFA is discussed, and an overview of clinical indications, results and complications is presented. One of the main problems in assessing the clinical value of RFA is the fact that no large and controlled randomized studies are available, while the number of ablations and treated tumor entities are steadily increasing. From a technical point of view, the major problem is the still limited volume of necrosis that is achievable. The indication for RFA has to be discussed interdisciplinarily. A complete tumor necrosis should be the aim of all ablations, with the exception of symptomatic metastases of neuroendocrine tumors. The value of additional chemotherapy to RFA is still unclear, especially in the treatment of liver metastases.

Radiofrequenzablation - Leber - Lebermetastasen - hepatozelluläres Karzinom

Radiofrequency ablation - liver - liver metastases - hepatocellular carcinoma

Literatur

• 1 Brodkey J S, Miyazaki Y, Ervin F R. et al . Reversible heat lesions with radio frequency current: A method of stereotactic localization.  J Neurosurg. 1964;  21 49-53
• 2 Anzai Y, Lufkin R, DeSalles A. et al . Preliminary experience with MR-guided thermal ablation of brain tumors.  AJNR Am J Neuroradiol. 1995;  16 39-48
• 3 Livraghi T, Goldberg S N, Monti F. et al . Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases.  Radiology. 1997;  202 205-210
• 4 Solbiati L, Goldberg S N, Ierace T. et al . Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes.  Radiology. 1997;  205 367-373
• 5 Zlotta A R, Wildschutz T, Raviv G. et al . Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience.  J Endourol. 1997;  11 251-258
• 6 Gadaleta C, Mattioli V, Colucci G. et al . Radiofrequency ablation of 40 lung neoplasms: preliminary results.  AJR Am J Roentgenol. 2004;  183 361-368
• 7 Rosenthal D I, Springfield D S, Gebhardt M C. et al . Osteoid osteoma: percutaneous radio-frequency ablation.  Radiology. 1995;  197 451-454
• 8 Zuber-Jerger I, Geissler M, Spangenberg H C. et al . Lokale Ablationsverfahren als Ergänzung der Therapie maligner Leberläsionen [Local ablation of malignant lesions of the liver - potential applications and limitations of the different methods].  Z Gastroenterol. 2004;  42 31-38
• 9 Goldberg S N, Gazelle G S, Compton C C. et al . Treatment of intrahepatic malignancy with radiofrequency ablation: Radiologic-pathologic correlation.  Cancer. 2000;  88 2452-2463
• 10 Pennes H H. Analysis of tissue and arterial blood temperatures in the resting human forearm.  J Appl Physiol. 1948;  1 93-122
• 11 Goldberg S N, Gazelle G S, Mueller P R. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance.  AJR Am J Roentgenol. 2000;  174 323-331
• 12 Aschoff A J, Merkle E M, Wong V. et al . How does alteration of hepatic blood flow affect liver perfusion and radiofrequency-induced thermal lesion size in rabbit liver?.  J Magn Reson Imaging. 2001;  13 57-63
• 13 Aschoff A J, Sulman A, Martinez M. et al . Perfusion-modulated MR imaging-guided radiofrequency ablation of the kidney in a porcine model.  AJR Am J Roentgenol. 2001;  177 151-158
• 14 Goldberg S N, Hahn P F, Tanabe K K. et al . Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?.  JVascIntervRadiol. 1998;  9 101-111
• 15 de Baere T, Bessoud B, Dromain C. et al . Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion.  AJR Am J Roentgenol. 2002;  178 53-59
• 16 McGahan J P, Browning P D, Brock J M. et al . Hepatic ablation using radiofrequency electrocautery.  InvestRadiol. 1990;  25 267-270
• 17 Denys A L, de Baere T, Kuoch V. et al . Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems.  Eur Radiol. 2003;  13 2346-2352
• 18 Pereira P L, Trubenbach J, Schenk M. et al . Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers.  Radiology. 2004;  232 482-490
• 19 Tacke J, Mahnken A, Roggan A. et al . Multipolar radiofrequency ablation: first clinical results.  Rofo. 2004;  176 324-329
• 20 Leyendecker J R, Dodd G D 3rd, Halff G A. et al . Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation.  AJR Am J Roentgenol. 2002;  178 1147-1151
• 21 Solbiati L, Arsizio B, Goldberg S N. et al . Microbubble ultrasound contrast agents: a useful adjunct for radiofrequency tumor ablation.  Radiology. 1997;  367
• 22 Solbiati L, Ierace T, Goldberg S N. et al . Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients.  Radiology. 1997;  202 195-203
• 23 Livraghi T, Goldberg S N, Lazzaroni S. et al . Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.  Radiology. 2000;  214 761-768
• 24 Livraghi T, Solbiati L, Meloni F. et al . Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the „test-of-time approach”.  Cancer. 2003;  97 3027-3035
• 25 Rossi S, Buscarini E, Garbagnati F. et al . Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode.  AJR Am J Roentgenol. 1998;  170 1015-1022
• 26 Rossi S, Fornari F, Buscarini E. Percutaneous Ultrasound-guided Radiofrequency Electrocautery for the Treatment of Small Hepatocellular Carcinoma.  Journal of Interventional Radiology. 1993;  8 97-103
• 27 Rossi S, SM, Buscarini E. et al . Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.  AJR Am J Roentgenol. 1996;  167 759-768
• 28 Rossi S, SM, Buscarini E. et al . Percutaneous Radiofrequency Interstitial Thermal Ablation in the Treatment of Small Hepatocellular Carcinoma.  Cancer J Sci Am. 1995;  1 73
• 29 Pereira P L, Düx M, Helmberger T. et al . Perkutane bildgesteuerte Leber-Tumortherapie mittels Radiofrequenz-Ablation (RFA). Leitlinien der „Experten-Gruppe Radiofrequenz-Ablation” in der Arbeitsgemeinschaft Interventionelle Radiologie der Deutschen Röntgengesellschaft 2003. http://www.drg-agir.de/BrennpunktRoefo300304.pdf. 
• 30 Lewin J S, Connell C F, Duerk J L. et al . Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility.  JMagnResonImaging. 1998;  8 40-47
• 31 Aschoff A J, Rafie N, Jesburger J A. et al . A Thermal lesion conspicuity following interstitial radiofrequency thermal tumor ablation in humans: a comparison of STIR, turbo spin echo T2-weighted, and contrast-enhanced T1-weighted MR images at 0.2 T.  J Magn Reson Imaging. 2000;  12 584-589
• 32 Mahnken A H, Buecker A, Spuentrup E. et al . MR-guided radiofrequency ablation of hepatic malignancies at 1.5 T: initial results.  J Magn Reson Imaging. 2004;  19 342-348
• 33 Huppert P E, Trübenbach J, Schick F. et al . MRT-gestützte perkutane Radiofrequenzablation hepatischer Neoplasien - Erste technische und klinische Erfahrungen. [MRI-guided percutaneous radiofrequency ablation of hepatic neoplasms - first technical and clinical experiences].  Rofo. 2000;  172 692-700
• 34 Limanond P, Zimmerman P, Raman S S. et al . Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies.  AJR Am J Roentgenol. 2003;  181 1635-1640
• 35 Pereira P L, Clasen S, Boss A. et al . Radiofrequenzablation von Lebermetastasen [Radiofrequency ablation of liver metastases].  Radiologe. 2004;  44 347-357
• 36 Elias D, Debaere T, Muttillo I. et al . Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection.  J Surg Oncol. 1998;  67 190-191
• 37 Henn A R, Levine E A, McNulty W. et al . Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes.  AJR Am J Roentgenol. 2003;  181 1005-1010
• 38 Siperstein A E, Rogers S J, Hansen P D. et al . Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases.  Surgery. 1997;  122 1147-1154
• 39 Decadt B, Siriwardena A K. Radiofrequency ablation of liver tumours: systematic review.  Lancet Oncol. 2004;  5 550-560
• 40 Mulier S, Mulier P, Ni Y. et al . Complications of radiofrequency coagulation of liver tumours.  Br J Surg. 2002;  89 1206-1222
• 41 Bowles B J, Machi J, Limm W M. et al . Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors.  Arch Surg. 2001;  136 864-869
• 42 Kettenbach J, Blum M, Kilanowicz E. et al . Perkutane Radiofrequenzablation von Leberzellkarzinomen: eine aktuelle Übersicht [Percutaneous radiofrequency ablation of liver cell carcinoma: a current overview].  Radiologe. 2004;  44 330-338
• 43 Lencioni R, Cioni D, Crocetti L. et al . Percutaneous ablation of hepatocellular carcinoma: state-of-the-art.  Liver Transpl. 2004;  10 S91-97
• 44 Elias D, de Baere T, Smayra T. et al . Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.  Br J Surg. 2002;  89 752-756
• 45 Livraghi T, Goldberg S N, Lazzaroni S. et al . Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection.  Radiology. 1999;  210 655-661
• 46 Kettenbach J, Kostler W, Rucklinger E. et al . Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients.  AJR Am J Roentgenol. 2003;  180 1537-1545
• 47 Hansler J, Frieser M, Schaber S. et al . Radiofrequency ablation of hepatocellular carcinoma with a saline solution perfusion device: a pilot study.  J Vasc Interv Radiol. 2003;  14 575-580
• 48 Dodd G D 3rd, Frank M S, Aribandi M. et al . Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations.  AJR Am J Roentgenol. 2001;  177 777-782
• 49 Ahmad S A. Limitations of radiofrequency ablation in treating liver metastases: a lesson in geometry.  Ann Surg Oncol. 2004;  11 358-359
• 50 Gillams A R, Lees W R. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer.  Dis Colon Rectum. 2000;  43 656-661
• 51 Hori T, Nagata K, Hasuike S. et al . Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.  J Gastroenterol. 2003;  38 977-981
• 52 Llovet J M, Vilana R, Bru C. et al . Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.  Hepatology. 2001;  33 1124-1129
• 53 Bleicher R J, Allegra D P, Nora D T. et al . Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned.  Ann Surg Oncol. 2003;  10 52-58
• 54 Pereira P L, Trubenbach J, Schmidt D. Radiofrequenzablation: Grundlagen, Techniken und Herausforderungen [Radiofrequency ablation: basic principles, techniques and challenges].  Rofo. 2003;  175 20-27